Shinji Chiba
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Successful application of lorlatinib in a 23-year-old patient with anaplastic lymphoma kinase (ALK)-positive lung cancer and multiple brain metastases.
Journal: Cancer reports (Hoboken, N.J.)
Published: August 02, 2023
A Case of Mediastinal Tuberculous Lymphadenitis in a Chronic Dialysis Patient Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA).
Journal: Medicina (Kaunas, Lithuania)
Published: February 26, 2023
High level of C-reactive protein as a predictive factor for immune-related adverse events of immune checkpoint inhibitors in non-small cell lung cancer: a retrospective study.
Journal: Journal of thoracic disease
Published: January 21, 2023
Treatment with immune checkpoint inhibitors after EGFR-TKIs in EGFR-mutated lung cancer.
Journal: Thoracic cancer
Published: October 05, 2021
Ⅰ. Development and Advances in Molecular Targeted Therapy for Lung Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 17, 2021
Combination treatment with bevacizumab plus erlotinib for meningeal carcinomatosis of afatinib-resistant EGFR mutated lung cancer without T790M mutation: a case report.
Journal: Annals of palliative medicine
Published: July 14, 2021
Impact of the genetic variants of GLCCI1 on clinical features of asthmatic patients.
Journal: The clinical respiratory journal
Published: January 02, 2017
Mitigation of tight junction protein dysfunction in lung microvascular endothelial cells with pitavastatin.
Journal: Pulmonary pharmacology & therapeutics
Published: January 23, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026